Company: AstraZeneca PLC

Bloomberg ticker: AZN LN

Market cap: US$200,088m

Background: AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology.

World Class Benchmarking of AstraZeneca

---

---

 

• Profitable Growth rank of 4 was down compared to the prior period’s 3rd rank
• This is above average performance compared to 380 large Health Care companies worldwide
• Profitability rank of 4 was better than its Growth rank of 7
• Profitability rank of 4 was the same compared to the prior period’s 4th rank
• This is above average performance compared to peers
• Growth rank of 7 was down compared to the prior period’s 1st rank
• This is below average performance compared to peers

 

---

DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.